|1.||Heikkilä, Pia: 2 articles (05/2006 - 03/2002)|
|2.||Sorsa, Timo: 2 articles (05/2006 - 03/2002)|
|3.||Salo, Tuula: 2 articles (05/2006 - 03/2002)|
|4.||Koivunen, Erkki: 2 articles (05/2006 - 01/2005)|
|5.||Zhang, Yajie: 1 article (09/2013)|
|6.||Long, Jie: 1 article (09/2013)|
|7.||Huang, Rongquan: 1 article (09/2013)|
|8.||Zhang, Huiqiu: 1 article (09/2013)|
|9.||Cheng, Jinwei: 1 article (01/2008)|
|10.||Cai, Jiping: 1 article (01/2008)|
|1.||Breast Neoplasms (Breast Cancer)
09/01/2013 - "To study the effect of the synthetic peptide RGDSY-CTTHWGFTLC on the biological behavior of breast cancer MCF-7 cells in vitro. "
02/01/2006 - "The peptide CTT (CTTHWGFTLC) was identified as a selective inhibitor of MMP-2/9 that inhibits the growth of MDA-MB-435 human breast cancer xenografts. "
09/01/2013 - "[The synthetic peptide RGDSY-CTTHWGFTLC inhibits metastasis and proliferation of breast cancer cells in vitro]."
|2.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/01/2006 - "In this study, we demonstrate that both the new hydrophilic derivate GRENYHGCTTHWGFTLC (CTT2) peptide and the CTT1 peptide inhibited specifically the human tongue squamous cell carcinoma (HSC-3) cell-derived gelatinolytic activity and in vitro invasion and migration of these cells (p < or = 0.049). "
01/01/2008 - "Synthetic peptide CTT (CTTHWGFTLC) has been found to suppress invasion and migration of both tumor and endothelial cells by potent and selective inhibition of MMP-2 and MMP-9. "
08/01/1999 - "Our prototype synthetic peptide, CTTHWGFTLC, inhibits the migration of human endothelial cells and tumor cells. "
01/01/2005 - "We have studied tumor radioimaging using a gelatinase inhibitory peptide CTTHWGFTLC (CTT), which in a mouse model targets the tumor site following an intravenous injection. "
|4.||Neoplasm Metastasis (Metastasis)
|5.||Melanoma (Melanoma, Malignant)
|2.||Alendronate (Alendronate Sodium)
|1.||Heterologous Transplantation (Xenotransplantation)